|
Volumn 342, Issue 15, 2000, Pages 1119-1120
|
High-dose chemotherapy plus autologous bone marrow transplantation for metastatic breast cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AUTOLOGOUS BONE MARROW TRANSPLANTATION;
BONE MARROW TRANSPLANTATION;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG MEGADOSE;
EDITORIAL;
FEMALE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
MAJOR CLINICAL STUDY;
METASTASIS;
PRIORITY JOURNAL;
PROGNOSIS;
TREATMENT OUTCOME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
COMBINED MODALITY THERAPY;
FEMALE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
NEOPLASM METASTASIS;
TREATMENT FAILURE;
|
EID: 0034643485
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200004133421508 Document Type: Editorial |
Times cited : (49)
|
References (7)
|